Clinical trial
Effect of IMN1207 Versus Casein on, Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients During or Following Chemotherapy, Radiation or Surgery: A Multi-center Randomized, Double-blind Study - Phase III Trial
NCT01046383 is registered in ClinicalTrials.gov with Immunotec Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of IMN1207 Versus Casein on, Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients During or Following Chemotherapy, Radiation or Surgery: A Multi-center Randomized, Double-blind Study - Phase III Trial
- Lead sponsor
- Immunotec Inc.
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- June 30, 2010
- Completion date
- June 30, 2013
- Enrollment
- 16 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
non-small cell lung cancer